National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

plitidepsin
A cyclic depsipeptide isolated from the marine tunicate Aplidium albicans. Plitidepsin displays a broad spectrum of antitumor activities, inducing apoptosis by triggering mitochondrial cytochrome c release, initiating the Fas/DC95, JNK pathway and activating caspase 3 activation. This agent also inhibits elongation factor 1-a, thereby interfering with protein synthesis, and induces G1 arrest and G2 blockade, thereby inhibiting tumor cell growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:aplidine
dehydrodemnin B
US brand name:Aplidin



Previous:Platinol, Platinol-AQ, plerixafor, plevitrexed, plicamycin
Next:pneumococcal polyvalent vaccine, Pneumovax 23, pNGVL3-hICD vaccine, pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine, PNP-expressing ovine atadenovirus FP253

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov